Retrorectal Tumor Surgery Shows Low Recurrence and High Survival Rates
Overview
A 25-year retrospective study of 61 patients undergoing surgical resection of retrorectal tumors demonstrated a 98% 5-year recurrence-free survival rate and a low local recurrence rate of 3%. Complete resection was achieved in all cases with minimal postoperative complications and no mortality.
Background
Retrorectal tumors are rare lesions located in the presacral space, presenting diagnostic and surgical challenges due to their heterogeneous nature. These tumors are often incidentally discovered during imaging for unrelated conditions. Surgical approach is typically guided by tumor location relative to the third sacral vertebra, with posterior or anterior approaches employed accordingly. Preoperative biopsy remains controversial due to potential complications and limited diagnostic benefit.
Data Highlights
Parameter
Value
Number of patients
61
Mean age
47 years
Female patients
81%
Mean tumor diameter
6 cm
Preoperative biopsy performed
12%
Posterior resection
91%
Anterior resection
3%
Combined approach
5%
Complete resection achieved
100%
Postoperative complications
7%
Recurrence rate
3%
5-year recurrence-free survival
98%
Mean hospital stay
~10 days
Key Findings
Complete surgical resection was achieved in all patients, with a 5-year recurrence-free survival rate of 98%.
Local recurrence occurred in only 3% of patients during follow-up up to 190 months.
Postoperative complications were low (7%) and included surgical site infections and fluid collections; no reoperations or mortality were reported.
Preoperative biopsy was performed in 12% of patients and was associated with a higher complication rate (29% vs 4%), though differences were not statistically significant.
Most tumors (95%) were benign, with tailgut cysts being the most common diagnosis (47%).
Imaging and surgical anatomy often provide sufficient information for surgical planning, reducing the need for routine biopsy.
Clinical Implications
Surgical resection of retrorectal tumors is effective and safe, with excellent long-term outcomes and low recurrence rates. Routine preoperative biopsy should be avoided due to its potential to increase complications and limited impact on surgical planning. Careful imaging assessment remains critical to guide the surgical approach and optimize patient outcomes.
Conclusion
This study supports complete surgical resection as the standard of care for retrorectal tumors, demonstrating low recurrence and complication rates. Selective use of preoperative biopsy is advised, emphasizing reliance on imaging for operative planning.
References
Kutluk et al. 2025 -- Retrorectal Surgery Linked to Low Recurrence
